HIV Counseling Intervention for Methadone-Maintained Patients - 2
NCT ID: NCT00061100
Last Updated: 2019-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
50 participants
INTERVENTIONAL
1999-10-31
2003-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Intervention Trial for HIV-infected Injection Drug Users
NCT00146445
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
NCT00432926
Development of a Methamphetamine Early Intervention
NCT01174654
HIV Prevention Counseling for Men Who Have Sex With Men
NCT00000931
HIV Prevention Intervention for Couples
NCT00325585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RISE intervention
Targeted RISE intervention- Behavior therapy Rise
Behavior Therapy-RISE
manually-guided HIV intervention RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounter
Standard Education
Education intervention. Standard prevention education
Standard prevention Education
standard psychosocial Education for HIV/hepatitis prevention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavior Therapy-RISE
manually-guided HIV intervention RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounter
Standard prevention Education
standard psychosocial Education for HIV/hepatitis prevention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give informed consent and capable of complying with study procedures
* Women who are of childbearing age and/or pregnant may be included
* Individuals who are HIV-positive or have Acquired Immunodeficiency Syndrome may be included
* Patients who demonstrate moderate to high HIV risk behaviors will be included
* Patients with low to no HIV risk behaviors will be excluded
* Patients receiving a stable dose of methadone for three weeks will be included
Exclusion Criteria
* Patients who have exhibited suicidal or homicidal behavior within the past two years
* HIV positive patients must have knowledge of their status for a minimum of three weeks
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frances R Levin
Director of Substance Use Disorder
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frances R Levin, M.D.
Role: PRINCIPAL_INVESTIGATOR
Research Foundation for Mental Hygiene, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Foundation for Mental Hygiene, Inc.
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3884
Identifier Type: OTHER
Identifier Source: secondary_id
#3884
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.